Home > Insider Trading > Filing (0001209191-21-068510)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1806310	Taysha Gene Therapies Inc.	TSHA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1701846	Ii R.a. Session	C/O Taysha Gene Therapies, Inc. 3000 Pegasus Park Drive, Suite 1430 Dallas TX 75247	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-11-23	16,510	$12.12	9,164,912	No	4	P	Direct
Common Stock	Acquisiton	2021-11-23	26,008	$12.65	9,190,920	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	141,090	Indirect	See footnote
Common Stock	141,090	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.46 to $12.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2).
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.46 to $12.94 inclusive.
The securities are held by RA Session II, as Trustee of the Session 2020 Annuity Trust I.
The securities are held by RA Session II, as Trustee of the Session 2020 Annuity Trust II.